Nemosis
Nemosis is a biological process that involves the non-apoptotic death of cells in response to external stimuli or stressors. This process is distinct from apoptosis, which is a form of programmed cell death. Nemosis is characterized by the formation of large, multinucleated cells, known as syncytia, and is often associated with chronic inflammation and disease progression.
Overview
Nemosis was first described in the late 20th century and has since been observed in a variety of cell types, including fibroblasts, epithelial cells, and endothelial cells. The process is triggered by various stimuli, such as mechanical stress, oxidative stress, and certain cytokines.
Mechanism
The exact mechanism of nemosis is not fully understood, but it is believed to involve a series of complex biochemical reactions. These reactions lead to changes in the cell cycle, resulting in the formation of syncytia. The syncytia are large, multinucleated cells that are formed through the fusion of multiple cells. This fusion is thought to be a protective response to stress, allowing the cells to share resources and resist damage.
Role in Disease
Nemosis has been implicated in a number of diseases, including cancer, rheumatoid arthritis, and atherosclerosis. In cancer, nemosis can contribute to tumor growth and progression by promoting the survival of cancer cells and inducing the production of pro-inflammatory cytokines. In rheumatoid arthritis, nemosis can lead to the formation of rheumatoid nodules, which are characteristic of the disease. In atherosclerosis, nemosis can contribute to the formation of atherosclerotic plaques by promoting the proliferation of smooth muscle cells.
Research and Future Directions
Research into nemosis is ongoing, with the aim of better understanding the process and its role in disease. This could potentially lead to the development of new therapeutic strategies for diseases in which nemosis plays a role.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
